The Lancet Respiratory Medicine: January 27, 2014

Victor Ortega discusses the effect of rare ADRB2 variants of risk on severe asthma exacerbations in patients receiving treatment with LABAs. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv